SUTRO BIOPHARMA, INC. (STRO) Free cash flow 2016–2018
SUTRO BIOPHARMA, INC. (STRO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$11.1MFY2018 · since FY2016: -$17.5M → $11.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | $11.1M | +127.5% |
| FY2017 | -$40.4M | -130.2% |
| FY2016 | -$17.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More STRO financial trends
STRO RevenueSTRO Net incomeSTRO Net marginSTRO Gross profitSTRO Gross marginSTRO Operating incomeSTRO Operating marginSTRO Operating cash flowSTRO Capital expendituresSTRO Return on equitySTRO Stock buybacksSTRO Dividends paidSTRO Total assetsSTRO Total liabilitiesSTRO Shareholders’ equitySTRO overview →